Description

The research project aims to identify the biomarkers linked to long COVID (LC) or to myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS). This study, lasting 12 months, seeks to deepen our understanding of the mechanisms of long COVID (LC) or of myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS), which could lead to improved early detection and to the implementation of personalized management strategies, thereby benefiting the people affected by these conditions. To reach these objectives, the research project will draw on virtual twin technology and untargeted metabolomic profiling, with particular emphasis on prognosis and monitoring.

Eligibility

Individuals living with myalgic encephalomyelitis

Objective

Understand and improve outcomes for myalgic encephalomyelitis (chronic fatigue syndrome).

Expected outcomes

  • Monitoring of variations in metabolites and biometric data during fatigue episodes and periods of normality
  • Innovative fatigue management tools to support health professionals with:
  • -Early detection
  • -Remote monitoring
  • -Risk assessment
  • -Risk assessment
  • -Prognosis
  • -Historical analysis